Drug firm Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules used for the treatment of high blood pressure.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sdoRCr
via IFTTT
0 comments:
Post a Comment